SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the?BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...
Cutting-edge facility to serve as a beacon for preventive medicine in Latin America MONTEVIDEO, Uruguay, April 22, 2024 /PRNewswire/ -- BGI Genomics, a global leader in integrated precision medicine solutions, has established a new clinical laboratory atUruguay's Parque de las Ciencias free trad...
HONG KONG, March 15, 2024 /PRNewswire/ -- Zhao Lijian, CEO of BGI Genomics, provided fresh insights on the company's vision during an exclusive interview withUzbekistan's National Television on Channel O'zbekiston24. This discussion was part of the "Focusing on the History of Uzbekistan-China Rel...
- Interviewing Wang?Leilei, the first blind model in China, and Viktoriya Tsay, head of Prenatal and Neonatal Medicine Department at Genscreen, BGI Genomics JV laboratory inUzbekistan. HONG KONG, March 8, 2024 /PRNewswire/ -- To mark International Women's Day (IWD), BGI Genomics interviewed Wang...
HONG KONG, Dec. 22, 2023 /PRNewswire/ -- BGI Genomics, the world's leading provider of integrated solutions for precision medicine, is pleased to announce winning Instagram Campaign (Gold) recognition at the Davos Communications Awards held onDecember 12, 2023. Organized by the World Communicati...
- Dr.?Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...
BANGKOK, Oct. 18, 2023 /PRNewswire/ -- "I have a dream that everyone should have the ability to access medical care equally," says?Oraphan Wanacharoen (Ice), BGI Genomics Field Application Scientist. "It's very challenging to achieve such a goal inThailand. With the advanced technology of the com...
* 61.6% of Thai women aged 21-25 years deterred by pap smears which is higher than the global average of 43.5% HONG KONG, July 28, 2023 /PRNewswire/ -- Only 28.5% of Thai women are diagnosed at stage I of cervical cancer when survival rates are highest, according to a?study
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally,?BGI Genomics released its State of Cervical Cancer Awareness Report today....
HONG KONG, June 30, 2023 /PRNewswire/ --?As businesses become increasingly global, changes are happening at an extraordinary pace. Compliance is critical for large economies, industry regulations, and enterprise operations. BGI Genomics prioritizes compliance management and strictly follows law...
HONG KONG, April 7, 2023 /PRNewswire/ -- To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics today released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world's third most commo...
SHENZHEN, China, June 15, 2022 /PRNewswire/ -- World Health Organization (WHO) has recently unveiled photos from its Feb-Mar 2021 visit to Hong Kong as COVID-19 affected the city, covering community testing facilities in key locations such as the Hong Kong International Airport and the Morse Park...
SHENZHEN, China, Sept. 3, 2021 /PRNewswire/ -- From April to August, 2021,?BGI's COVID-19 testing?lab has?helped?5,500 Chinese travelers safely fly out of??the Addis Ababa Bole International Airport. In April, BGI set up the "Huo-Yan" laboratory, a COVID-19 testing lab, at the?airport for pass...
SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the company's non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI's NIPT tests have been used around the world to identify genetic conditions in pregnancy. These tests provide ...
SHENZHEN, China, May 11, 2020 /PRNewswire/ -- BGI Genomics announced that its Real-time fluorescent RT-PCR kit for detecting 2019-nCoV has been listed?as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process.? The EUL is a risk-based procedure...
SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent division of?BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price ofRMB 13.64 per share. Announces launch of IPO BG...